Treatment of Sleep-disordered Breathing in Patients With SCI
Does Treatment of Sleep-Disordered Breathing Improve Functional Outcomes in SCI
2 other identifiers
interventional
73
1 country
1
Brief Summary
Sleep-disordered breathing (SDB) remains under-treated in individuals living with spinal cord injuries and disorders (SCI/D). The investigators' aim is to test a program that addresses challenges and barriers to positive airway pressure (PAP) treatment of SDB among patients with SCI/D. The investigators anticipate that patients who receive this program will have higher rates of PAP use and will demonstrate improvements in sleep quality, general functioning, respiratory functioning and quality of life from baseline to 6 months follow up compared to individuals who receive a control program. This work addresses critical healthcare needs for patients with SCI/D and may lead to improved health and quality of life for these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2016
CompletedFirst Posted
Study publicly available on registry
July 12, 2016
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedResults Posted
Study results publicly available
April 22, 2021
CompletedMay 19, 2021
April 1, 2021
2.4 years
July 7, 2016
February 4, 2021
April 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
PAP Adherence
Number of nights positive airway pressure (PAP) was used \>=4 hours during the first 90 days measured by remote monitoring. Scores range from 0 to 90 days. Higher scores indicate better outcome.
90 days
Subjective Sleep Quality Was Measured by The Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index (PSQI) is an 18-item questionnaire that assesses sleep quality and disturbances over the past month. The PSQI is sensitive for distinguishing normal and abnormal sleepers and has good test-retest reliability. The investigators will use the 3-factor scoring, which has been shown to have superior psychometric properties. This will be used as the main independent measure of sleep quality. The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality
90 days
Secondary Outcomes (6)
Quality of Life Was Measured by WHO-QOL BREF Questionnaire
90 days
Respiratory Function: Spirometry and Respiratory Muscle Force
90 days
Functional Status Was Measured by CHART Questionnaire.
90 days
Depressive Symptom Severity
90 days
Fatigue Symptoms
90 days
- +1 more secondary outcomes
Study Arms (2)
The BEST Program
EXPERIMENTALa combined sleep and PAP adherence program, called the BEST program (Best practices PAP + patient Education + ongoing Support and Training)
Sleep Education and standard SDB treatment
ACTIVE COMPARATORThis program includes non-directive sleep education plus standard treatment of SDB.
Interventions
This is a combined sleep and PAP adherence program, called the "BEST" program (Best practices PAP + Education + ongoing Support/Training
This program includes non-directive sleep education plus standard treatment of SDB.
Eligibility Criteria
You may qualify if:
- Adult patients with chronic SCI/D (\>3 months post injury)
- American Spinal Injury Association (ASIA) classification A-D (i.e., excluding those with no evidence of a neurologic deficit based on ASIA classification).
You may not qualify if:
- Patients receiving mechanical ventilation
- already using PAP for SDB at optimal compliance
- A clinical contraindication that prevents PAP use.
- recent health event that may affect sleep, e.g.:
- CVA
- acute MI
- recent surgery or hospitalization
- alcohol or substance abuse (\<90 days sobriety)
- self-described as too ill to engage in study procedures
- unable to provide self-consent for participation (e.g., due to dementia)
- the investigators will offer to re-contact patients 90 days after a health event or after 90 days of sobriety
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, 48201, United States
Related Publications (3)
Badr AN, Zeineddine S, Salloum A, Pandya N, Mitchell MN, Sankari A, Munoz ID, Badr MS, Martin JL, Kelly MR. Sleep and daytime function in people with spinal cord injury. J Clin Sleep Med. 2025 Nov 1;21(11):1903-1909. doi: 10.5664/jcsm.11804.
PMID: 40590079DERIVEDBadr MS, Martin JL, Sankari A, Zeineddine S, Salloum A, Henzel MK, Strohl K, Shamim-Uzzaman A, May AM, Fung CH, Pandya N, Carroll S, Mitchell MN. Intensive support does not improve positive-airway pressure use in spinal cord injury/disease: a randomized clinical trial. Sleep. 2024 May 10;47(5):zsae044. doi: 10.1093/sleep/zsae044.
PMID: 38422375DERIVEDKelly MR, Zeineddine S, Mitchell MN, Sankari A, Pandya N, Carroll S, Shamim-Uzzaman QA, Salloum A, Badr MS, Martin JL. Insomnia severity predicts depression, anxiety, and posttraumatic stress disorder in veterans with spinal cord injury or disease: a cross-sectional observational study. J Clin Sleep Med. 2023 Apr 1;19(4):695-701. doi: 10.5664/jcsm.10410.
PMID: 36661092DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. M.Safwan Badr, MD, Ph.D.
- Organization
- John D. Dingell VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
M S Badr, MD
John D. Dingell VA Medical Center, Detroit, MI
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2016
First Posted
July 12, 2016
Study Start
May 1, 2017
Primary Completion
September 30, 2019
Study Completion
March 30, 2020
Last Updated
May 19, 2021
Results First Posted
April 22, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share